论文部分内容阅读
本院自1988年至1990年对26例晚期肺癌病人进行了选择性支气管动脉灌注治疗,收到了较为满意的近期疗效,现报道如下。1 资料与方法1.1 一般资料.男22例,女4例。年龄33～70岁,平均年龄57岁。鳞癌18例,腺癌1例,大细胞未分化癌1例,肺癌未分类6例。按全国肺癌协作会议分期标准,Ⅱ期8例,Ⅲ期10例,Ⅳ期8例。1.2 方法.灌注治疗采用Seldinger法,经皮股动脉穿刺插管,将眼镜蛇(COBRA)-C_2或C_3导管尖端送至主动脉第5～6胸椎水平或左主支气管附近,指向病侧壁或前、后壁上下移动。一旦导管尖端插入支气管动脉内,手推60％泛影葡胺3～5ml,认定是
In our hospital from 1988 to 1990, 26 patients with advanced lung cancer were treated with selective bronchial arterial infusion therapy and received relatively satisfactory short-term results. The report is as follows. 1 Materials and methods 1.1 General information. There are 22 males and 4 females. Age 33 to 70 years, mean age 57 years. There were 18 cases of squamous cell carcinoma, 1 case of adenocarcinoma, 1 case of large-cell undifferentiated carcinoma, and 6 cases of unclassified lung cancer. According to the staging criteria of the National Lung Cancer Collaboration Conference, there were 8 cases in Phase II, 10 cases in Phase III, and 8 cases in Phase IV. 1.2 Methods. Infusion therapy using Seldinger method, percutaneous femoral artery puncture cannula, the cobra (COBRA) - C2 or C_3 catheter tip sent to the aortic 5 ~ 6 thoracic level or near the left main bronchus, pointing to the side or front of the disease The back wall moves up and down. Once the tip of the catheter is inserted into the bronchial artery, 60% diatrizoate 3 to 5 ml is pushed and it is determined that